Biomedical subjects
M Spatz
Publications and source records attributed to M Spatz.
Quantitative changes with age in the DNA content of methylazoxymethanol-induced microencephalic rat brain.
Explore the source record for details and available documents.
Tryptophan metabolism and cardiac disease.
Explore the source record for details and available documents.
Intellectual deficit associated with transplacentally induced microcephaly in the rat.
Fischer rats injected with methylazoxymethanol late in pregnancy produce young with considerably reduced cerebral hemispheres. They appear normal otherwise. As adults these animals make many more errors in the Hebb-Williams maze than do control animals.
Evidence for transplacental passage of the natural carcinogen cycasin and its aglycone.
Explore the source record for details and available documents.
Transplacental chemical induction of microencephaly in two strains of rats. I.
Explore the source record for details and available documents.
Transplantability of cycasin-induced tumors in rats, with emphasis on nephroblastomas.
Explore the source record for details and available documents.
Tumor induction in Fischer and Osborne-Mendel rats by a single administration of cycasin.
Explore the source record for details and available documents.
Papillary transitional cell tumor of bladder in a 5-year-old boy.
Explore the source record for details and available documents.
Teratogenic effects of methylazoxymethanol.
Explore the source record for details and available documents.
Role of intestinal microorganisms in determining cycasin toxicity.
Explore the source record for details and available documents.
Transplacental induction of tumors in Sprague-Dawley rats with crude cycad material.
Explore the source record for details and available documents.
Myocardial "protective effect" of 5-OH tryptamine during tryptophan deficiency.
Explore the source record for details and available documents.
Cycasin excretion in conventional and germfree rats.
Explore the source record for details and available documents.
Paradoxical interactions among estrogen receptors, estrogens and SERMS: mutual annihilation and synergy.
The phenomenon of mutual annihilation of action between 17beta estradiol (E(2)) and a selective estrogen receptor modulator (SERM), previously described in prepubertal rat diaphysis, epiphysis and uterus, has been investigated in ROS 17/2.8 rat osteoblastic cells and in transiently co-transfected cells in culture. In ROS 17/2.8 cells, the estrogen-induced marker enzyme creatine kinase B (CKB) was stimulated by raloxifene, tamoxifen and tamoxifen methiodide to a specific activity equal to or greater than that induced by 10 nM E(2). However, when a fully inhibitory dose of any of these SERMS was given simultaneously with E(2), no stimulation of CK activity resulted. Therefore, SERMS can be full agonists when acting alone, but complete antagonists to a super-physiological dose of estrogen. It is expected that excess tamoxifen would prevent the action of a SERM, but that the agonist activity of a SERM is abolished by 1000-fold less estrogen is a phenomenon without obvious explanation by classical pharmacology of competitive inhibition. To probe the mechanism of this interaction further, a ckb-CAT reporter plasmid, plus the human receptor expression plasmid, HEO, was transfected transiently into several cell types. In MCF-7 cells, a 1:10 ratio of E(2) to tamoxifen produced mutual annihilation, but the same ratio in ROS 17/2.8 or HeLa cells led to synergistic stimulation. In HeLa cells, co-transfected with the more efficient wild-type estrogen receptor plasmid, HEGO, synergy was demonstrated only at sub-saturation levels of HEGO. We speculate that, in the presence of estradiol and a SERM, not only active homodimers would be formed, but also hetero-dimers of estrogen-liganded and tamoxifen-liganded receptor monomers, depending on the molar ratio of their ligands and their relative affinities. The resulting hetero-dimer conformation would change the specific receptor surface for interactions with the growing number of co-activators and co-repressors, structural changes which could help to explain the mutual annihilation and synergy phenomena and their cell selectivity.
Effects of oxygen saturation and pCO2 on brain uptake of glucose analogues in rabbits.
The effect of oxygen saturation and PCO2 on brain uptake of glucose analogues was studied in rabbits. Using a modified Oldendorf technique, 14C-labeled glucose analogues with a 3H2O reference standard were introduced into the cerebral circulation via the common carotid artery, and the radioactivity of the ipsilateral cerebral cortex was counted and expressed in terms of a brain uptake index (BUI). Severe hypoxia (oxygen saturation less than or equal to 18%) resulted in approximately a 40% decrease in the BUI of 2-deoxy-D-glucose and a 45% decrease in the BUI of 3-0-methyl-D-glucose. Severe hypercapnia (PCO2 = 100 mm Hg) caused a 45% decrease in the BUI of both of these glucose analogues. Hypercapnia superimposed on severe hypoxia had no additional effect. Hypocapnia (PCO2 = 15 mm Hg) increased the BUI of 3-0-methyl-D-glucose by 35% of the control value, and this increase was extremely sensitive to competitive inhibition. When BUI values were plotted against pH rather than PCO2 for the same experiments, there was a good correlation with the calculated linear regression. These results are compared with previous findings on pathologically induced changes in brain uptake of glucose analogues, and the possible role of blood flow is considered in detail.
[Postischemic disorders and the therapeutic measures in brain ischemia].
Explore the source record for details and available documents.